{"transactions":[{"id":3522665,"issuer":{"id":8309,"kind":"organization","name":"Autonomix Medical, Inc.","symbol":"AMIX"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-08T20:23:39.000Z","date":"2026-09-03","kind":"grant","planned":false,"acquired":true,"shares":13000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026."}],"balance_after":20118,"source":{"system":"sec-edgar","filing":"0001437749-26-029835","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926029835/rdgdoc.xml","form_type":"4"}},{"id":696256,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Series I Warrants","published_at":"2026-08-05T20:16:13.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":1599999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":1926335,"derivative":{"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":1599999},"source":{"system":"sec-edgar","filing":"0001437749-26-025928","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926025928/rdgdoc.xml","form_type":"4"}},{"id":696255,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-08-05T20:16:13.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":533333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":564340,"source":{"system":"sec-edgar","filing":"0001437749-26-025928","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926025928/rdgdoc.xml","form_type":"4"}},{"id":728159,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 1,439 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 1,439 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 250,002 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":326336,"derivative":{"underlying":"Common Stock","underlying_shares":360},"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728158,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 250,002 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":326696,"derivative":{"underlying":"Common Stock","underlying_shares":150},"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728157,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":88,"price":3.12,"value":274.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":31007,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728156,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":31088,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728155,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":37,"price":2.88,"value":106.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":30728,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728154,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":30765,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":999391,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Performance Based Restricted Stock Units","published_at":"2025-11-14T21:07:49.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest."}],"balance_after":3960731,"derivative":{"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001437749-25-035182","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925035182/rdgdoc.xml","form_type":"4"}},{"id":999390,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2025-11-14T21:07:49.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":830000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":3210731,"derivative":{"exercise_price":0.49,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":830000},"source":{"system":"sec-edgar","filing":"0001437749-25-035182","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925035182/rdgdoc.xml","form_type":"4"}},{"id":1006166,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:24:54.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":false,"shares":28750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2380731,"derivative":{"underlying":"Common Stock","underlying_shares":28750},"source":{"system":"sec-edgar","filing":"0001437749-25-033683","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925033683/rdgdoc.xml","form_type":"4"}},{"id":1006165,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:54.000Z","date":"2025-11-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":7001,"price":0.497,"value":3479.497,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":765356,"source":{"system":"sec-edgar","filing":"0001437749-25-033683","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925033683/rdgdoc.xml","form_type":"4"}},{"id":1006164,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:54.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":true,"shares":28750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":772357,"source":{"system":"sec-edgar","filing":"0001437749-25-033683","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925033683/rdgdoc.xml","form_type":"4"}},{"id":1068207,"issuer":{"id":8309,"kind":"organization","name":"Autonomix Medical, Inc.","symbol":"AMIX"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true}}],"security":"Option (Right to buy)","published_at":"2025-08-14T01:13:57.000Z","date":"2025-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8773,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation."},{"field":"shares","element":"transactionShares","label":"F1","text":"Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount represents a revised share amount based on a 1-for-20 reverse stock split from October 25,2024."}],"balance_after":1250,"derivative":{"exercise_price":26.56,"exercise_date":"2025-06-21","expiration_date":"2034-06-21","underlying":"Common Stock","underlying_shares":8773},"source":{"system":"sec-edgar","filing":"0001437749-25-026638","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925026638/rdgdoc.xml","form_type":"4"}},{"id":1104268,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Series E Warrants","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":false,"shares":2027025,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":2409481,"derivative":{"exercise_price":0.37,"underlying":"Common Stock","underlying_shares":2027025},"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104267,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":false,"shares":8990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":382456,"derivative":{"underlying":"Common Stock","underlying_shares":8990},"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104266,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 15,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 15,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":391446,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104265,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":675675,"price":0.37,"value":249999.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":743607,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104264,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2190,"price":0.267,"value":584.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":67932,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104263,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":true,"shares":8990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":70122,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104262,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":914,"price":0.267,"value":244.038,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":61132,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104261,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":62046,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1106860,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-06-19T01:00:17.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":370075,"derivative":{"underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-25-020802","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925020802/rdgdoc.xml","form_type":"4"}},{"id":1106859,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-19T01:00:17.000Z","date":"2025-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":406,"price":0.6852,"value":278.1912,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards"}],"balance_after":58296,"source":{"system":"sec-edgar","filing":"0001437749-25-020802","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925020802/rdgdoc.xml","form_type":"4"}},{"id":1106858,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-19T01:00:17.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":1667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":58702,"source":{"system":"sec-edgar","filing":"0001437749-25-020802","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925020802/rdgdoc.xml","form_type":"4"}},{"id":1374582,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Performance Based Restricted Stock Units","published_at":"2024-11-07T01:00:17.000Z","date":"2024-10-25","kind":"grant","planned":false,"acquired":true,"shares":43590,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On December 29, 2023, the Board approved this performance based restricted stock unit, subject to shareholder approval of the stock plan. The performance based restricted stock units set forth in this table will vest only upon both (A) the approval of the Plan Amendment by the Company stockholders; and (B) the first of the following to occur: (a) a licensing transaction with a valuation, at the time, in excess of $150 million, which valuation shall be determined by the Board; (b) the filing of a new drug application; or (c) upon a Change in Control (as defined in the Plan), in each case subject to the respective executive officer's continued service with the Company at each such vesting date."}],"balance_after":371742,"derivative":{"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":43590},"source":{"system":"sec-edgar","filing":"0001437749-24-033703","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924033703/rdgdoc.xml","form_type":"4"}},{"id":1374581,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-11-07T01:00:17.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":115000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":328152,"derivative":{"underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001437749-24-033703","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924033703/rdgdoc.xml","form_type":"4"}},{"id":1374580,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:00:17.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":213152,"derivative":{"exercise_price":2.45,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-033703","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924033703/rdgdoc.xml","form_type":"4"}},{"id":1459035,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-07-05T21:01:18.000Z","date":"2024-07-02","kind":"exercise","planned":false,"acquired":false,"shares":982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 3,926 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 3,926 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":113152,"derivative":{"underlying":"Common Stock","underlying_shares":982},"source":{"system":"sec-edgar","filing":"0001437749-24-022252","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924022252/rdgdoc.xml","form_type":"4"}},{"id":1459034,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-07-05T21:01:18.000Z","date":"2024-07-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":240,"price":3.57,"value":856.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":57035,"source":{"system":"sec-edgar","filing":"0001437749-24-022252","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924022252/rdgdoc.xml","form_type":"4"}},{"id":1459033,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-07-05T21:01:18.000Z","date":"2024-07-02","kind":"exercise","planned":false,"acquired":true,"shares":982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":57275,"source":{"system":"sec-edgar","filing":"0001437749-24-022252","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924022252/rdgdoc.xml","form_type":"4"}},{"id":1469914,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:00:56.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":false,"shares":8990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":114134,"derivative":{"underlying":"Common Stock","underlying_shares":8990},"source":{"system":"sec-edgar","filing":"0001437749-24-021197","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924021197/rdgdoc.xml","form_type":"4"}},{"id":1469913,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-25T22:00:56.000Z","date":"2024-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2190,"price":3.74,"value":8190.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":56293,"source":{"system":"sec-edgar","filing":"0001437749-24-021197","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924021197/rdgdoc.xml","form_type":"4"}},{"id":1469912,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-25T22:00:56.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":true,"shares":8990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":58483,"source":{"system":"sec-edgar","filing":"0001437749-24-021197","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924021197/rdgdoc.xml","form_type":"4"}},{"id":1471280,"issuer":{"id":8309,"kind":"organization","name":"Autonomix Medical, Inc.","symbol":"AMIX"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true}}],"security":"Option (Right to buy)","published_at":"2024-06-24T21:09:31.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":175452,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option set forth in this table vests in four annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":200452,"derivative":{"exercise_price":1.328,"expiration_date":"2034-06-21","underlying":"Common Stock","underlying_shares":175452},"source":{"system":"sec-edgar","filing":"0001437749-24-021105","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924021105/rdgdoc.xml","form_type":"4"}},{"id":1472467,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-06-21T21:00:55.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 15,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 15,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":123124,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001437749-24-020995","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924020995/rdgdoc.xml","form_type":"4"}},{"id":1472466,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-21T21:00:55.000Z","date":"2024-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":914,"price":3.78,"value":3454.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":49493,"source":{"system":"sec-edgar","filing":"0001437749-24-020995","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924020995/rdgdoc.xml","form_type":"4"}},{"id":1472465,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-21T21:00:55.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":50407,"source":{"system":"sec-edgar","filing":"0001437749-24-020995","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924020995/rdgdoc.xml","form_type":"4"}},{"id":1476218,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-06-18T21:01:20.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":126874,"derivative":{"underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-24-020663","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924020663/rdgdoc.xml","form_type":"4"}},{"id":1476217,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-18T21:01:20.000Z","date":"2024-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":406,"price":4.14,"value":1680.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":46657,"source":{"system":"sec-edgar","filing":"0001437749-24-020663","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924020663/rdgdoc.xml","form_type":"4"}},{"id":1476216,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-18T21:01:20.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":true,"shares":1667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":47063,"source":{"system":"sec-edgar","filing":"0001437749-24-020663","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924020663/rdgdoc.xml","form_type":"4"}},{"id":1699767,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-27T12:31:05.000Z","date":"2023-12-26","kind":"purchase","planned":false,"acquired":true,"shares":188404,"price":0.69,"value":129998.76,"ownership":{"direct":true},"balance_after":680880,"source":{"system":"sec-edgar","filing":"0001437749-23-035340","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923035340/rdgdoc.xml","form_type":"4"}},{"id":1830550,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2023-07-13T22:35:24.000Z","date":"2023-07-11","kind":"exercise","planned":false,"acquired":false,"shares":13204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1928145,"derivative":{"underlying":"Common Stock","underlying_shares":13204},"source":{"system":"sec-edgar","filing":"0001437749-23-019907","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923019907/rdgdoc.xml","form_type":"4"}},{"id":1830549,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-07-13T22:35:24.000Z","date":"2023-07-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3216,"price":0.5903,"value":1898.4048,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":492476,"source":{"system":"sec-edgar","filing":"0001437749-23-019907","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923019907/rdgdoc.xml","form_type":"4"}},{"id":1830548,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-07-13T22:35:24.000Z","date":"2023-07-11","kind":"exercise","planned":false,"acquired":true,"shares":13204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":495692,"source":{"system":"sec-edgar","filing":"0001437749-23-019907","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923019907/rdgdoc.xml","form_type":"4"}},{"id":1837774,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T22:00:14.000Z","date":"2023-07-02","kind":"exercise","planned":false,"acquired":false,"shares":14717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1941349,"derivative":{"underlying":"Common Stock","underlying_shares":14717},"source":{"system":"sec-edgar","filing":"0001437749-23-019412","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923019412/rdgdoc.xml","form_type":"4"}},{"id":1837773,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-07-05T22:00:14.000Z","date":"2023-07-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3584,"price":0.5788,"value":2074.4192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":482488,"source":{"system":"sec-edgar","filing":"0001437749-23-019412","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923019412/rdgdoc.xml","form_type":"4"}},{"id":1837772,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-07-05T22:00:14.000Z","date":"2023-07-02","kind":"exercise","planned":false,"acquired":true,"shares":14717,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":486072,"source":{"system":"sec-edgar","filing":"0001437749-23-019412","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923019412/rdgdoc.xml","form_type":"4"}},{"id":1844575,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2023-06-26T22:20:18.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":539375,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company.Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1956066,"derivative":{"underlying":"Common Stock","underlying_shares":539375},"source":{"system":"sec-edgar","filing":"0001437749-23-018529","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923018529/rdgdoc.xml","form_type":"4"}},{"id":1844574,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2023-06-26T22:20:18.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company.Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1416691,"derivative":{"exercise_price":0.6,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-23-018529","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923018529/rdgdoc.xml","form_type":"4"}},{"id":1847017,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2023-06-22T23:00:40.000Z","date":"2023-06-20","kind":"exercise","planned":false,"acquired":false,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 225,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 225,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1016691,"derivative":{"underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001437749-23-018140","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923018140/rdgdoc.xml","form_type":"4"}},{"id":1847016,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-22T23:00:40.000Z","date":"2023-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":13697,"price":0.57,"value":7807.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":471355,"source":{"system":"sec-edgar","filing":"0001437749-23-018140","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923018140/rdgdoc.xml","form_type":"4"}},{"id":1847015,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-22T23:00:40.000Z","date":"2023-06-20","kind":"exercise","planned":false,"acquired":true,"shares":56250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":485052,"source":{"system":"sec-edgar","filing":"0001437749-23-018140","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923018140/rdgdoc.xml","form_type":"4"}},{"id":1850492,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2023-06-20T22:00:13.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 100,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 100,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1072941,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-23-017884","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923017884/rdgdoc.xml","form_type":"4"}},{"id":1850491,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-20T22:00:13.000Z","date":"2023-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":6088,"price":0.57,"value":3470.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":428802,"source":{"system":"sec-edgar","filing":"0001437749-23-017884","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923017884/rdgdoc.xml","form_type":"4"}},{"id":1850490,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-20T22:00:13.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":434890,"source":{"system":"sec-edgar","filing":"0001437749-23-017884","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774923017884/rdgdoc.xml","form_type":"4"}},{"id":2103688,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-11-28T23:00:26.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":45000,"price":1.2807,"value":57631.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.25 to $1.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":409890,"source":{"system":"sec-edgar","filing":"0001437749-22-028116","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922028116/rdgdoc.xml","form_type":"4"}},{"id":2105680,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-11-23T13:30:28.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":22500,"price":1.1496,"value":25866.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.12 to $1.17. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":364890,"source":{"system":"sec-edgar","filing":"0001437749-22-027949","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922027949/rdgdoc.xml","form_type":"4"}},{"id":2110877,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-11-19T01:34:16.000Z","date":"2022-11-17","kind":"purchase","acquired":true,"shares":24742,"price":1.0208,"value":25256.6336,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $0.995 to $1.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":342390,"source":{"system":"sec-edgar","filing":"0001437749-22-027792","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922027792/rdgdoc.xml","form_type":"4"}},{"id":2110876,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-11-19T01:34:16.000Z","date":"2022-11-16","kind":"purchase","acquired":true,"shares":85213,"price":0.9695,"value":82614.0035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.935 to $1.02. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":317648,"source":{"system":"sec-edgar","filing":"0001437749-22-027792","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922027792/rdgdoc.xml","form_type":"4"}},{"id":2207246,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2022-07-16T00:04:22.000Z","date":"2022-07-02","kind":"exercise","acquired":false,"shares":14717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1111145,"derivative":{"underlying":"Common Stock","underlying_shares":14717},"source":{"system":"sec-edgar","filing":"0001437749-22-017220","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017220/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-07-06"}},{"id":2207245,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-16T00:04:22.000Z","date":"2022-07-02","kind":"tax_withholding","acquired":false,"shares":3584,"price":1.47,"value":5268.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":222446,"source":{"system":"sec-edgar","filing":"0001437749-22-017220","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017220/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-07-06"}},{"id":2207244,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-16T00:04:22.000Z","date":"2022-07-02","kind":"exercise","acquired":true,"shares":14717,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":226030,"source":{"system":"sec-edgar","filing":"0001437749-22-017220","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017220/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-07-06"}},{"id":2207243,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2022-07-16T00:03:45.000Z","date":"2022-07-11","kind":"exercise","acquired":false,"shares":13205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1097941,"derivative":{"underlying":"Common Stock","underlying_shares":13204},"source":{"system":"sec-edgar","filing":"0001437749-22-017219","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017219/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-07-13"}},{"id":2207242,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-16T00:03:45.000Z","date":"2022-07-11","kind":"tax_withholding","acquired":false,"shares":3215,"price":1.68,"value":5401.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":232435,"source":{"system":"sec-edgar","filing":"0001437749-22-017219","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017219/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-07-13"}},{"id":2207241,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-16T00:03:45.000Z","date":"2022-07-11","kind":"exercise","acquired":true,"shares":13204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":235650,"source":{"system":"sec-edgar","filing":"0001437749-22-017219","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017219/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-07-13"}},{"id":2207240,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2022-07-16T00:03:09.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on\neach vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on\neach vesting date."}],"balance_after":1125862,"derivative":{"underlying":"Common stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001437749-22-017218","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017218/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-06-22"}},{"id":2207239,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2022-07-16T00:03:09.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each\nvesting date."}],"balance_after":900862,"derivative":{"exercise_price":1.49,"expiration_date":"2032-06-20","underlying":"Common stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001437749-22-017218","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017218/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-06-22"}},{"id":2208223,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2022-07-13T21:00:21.000Z","date":"2022-07-11","kind":"exercise","acquired":false,"shares":13205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1369941,"derivative":{"underlying":"Common Stock","underlying_shares":13204},"source":{"system":"sec-edgar","filing":"0001437749-22-017075","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017075/rdgdoc.xml","form_type":"4"}},{"id":2208222,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-13T21:00:21.000Z","date":"2022-07-11","kind":"tax_withholding","acquired":false,"shares":3215,"price":1.68,"value":5401.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":232435,"source":{"system":"sec-edgar","filing":"0001437749-22-017075","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017075/rdgdoc.xml","form_type":"4"}},{"id":2208221,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-13T21:00:21.000Z","date":"2022-07-11","kind":"exercise","acquired":true,"shares":13204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":235650,"source":{"system":"sec-edgar","filing":"0001437749-22-017075","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922017075/rdgdoc.xml","form_type":"4"}},{"id":2212765,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2022-07-06T22:02:07.000Z","date":"2022-07-02","kind":"exercise","acquired":false,"shares":14717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1383145,"derivative":{"underlying":"Common Stock","underlying_shares":14717},"source":{"system":"sec-edgar","filing":"0001437749-22-016754","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922016754/rdgdoc.xml","form_type":"4"}},{"id":2212764,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-06T22:02:07.000Z","date":"2022-07-02","kind":"tax_withholding","acquired":false,"shares":3584,"price":1.47,"value":5268.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":222446,"source":{"system":"sec-edgar","filing":"0001437749-22-016754","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922016754/rdgdoc.xml","form_type":"4"}},{"id":2212763,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-06T22:02:07.000Z","date":"2022-07-02","kind":"exercise","acquired":true,"shares":14717,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":226030,"source":{"system":"sec-edgar","filing":"0001437749-22-016754","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922016754/rdgdoc.xml","form_type":"4"}},{"id":2224562,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2022-06-22T23:04:19.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":362000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1397862,"derivative":{"underlying":"Common stock","underlying_shares":362000},"source":{"system":"sec-edgar","filing":"0001437749-22-015663","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922015663/rdgdoc.xml","form_type":"4"}},{"id":2224561,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2022-06-22T23:04:19.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":360000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1035862,"derivative":{"exercise_price":1.49,"expiration_date":"2032-06-20","underlying":"Common stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001437749-22-015663","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922015663/rdgdoc.xml","form_type":"4"}},{"id":2226075,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2022-06-22T00:08:20.000Z","date":"2022-06-16","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 100,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 100,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":675862,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-22-015536","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922015536/rdgdoc.xml","form_type":"4"}},{"id":2226074,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-06-22T00:08:20.000Z","date":"2022-06-16","kind":"tax_withholding","acquired":false,"shares":6088,"price":1.33,"value":8097.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":211313,"source":{"system":"sec-edgar","filing":"0001437749-22-015536","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922015536/rdgdoc.xml","form_type":"4"}},{"id":2226073,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-06-22T00:08:20.000Z","date":"2022-06-16","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":217401,"source":{"system":"sec-edgar","filing":"0001437749-22-015536","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774922015536/rdgdoc.xml","form_type":"4"}},{"id":2468404,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":7771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-11-15","underlying":"Common Stock","underlying_shares":7771},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468403,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":8634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-10-30","underlying":"Common Stock","underlying_shares":8634},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468402,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":11512,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-10-19","underlying":"Common Stock","underlying_shares":11512},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468401,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":113000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":9.74,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":113000},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468400,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":89300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":11.71,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":89300},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468399,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":35150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":14.62,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":35150},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468398,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":84500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2029-02-04","underlying":"Common Stock","underlying_shares":84500},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468397,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":725000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the Merger Consideration minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":725000},"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2468396,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-12-17T22:09:35.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":425000,"price":22.6,"value":9605000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), at the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), these shares of Company common stock were converted into the right to receive $22.60 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), at the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), these shares of Company common stock were converted into the right to receive $22.60 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001548187-21-000079","document":"wf-form4_163977896166120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000079/wf-form4_163977896166120.xml","form_type":"4"}},{"id":2636482,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2021-07-12T21:57:44.000Z","date":"2021-07-11","kind":"exercise","acquired":false,"shares":13205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":700862,"derivative":{"underlying":"Common Stock","underlying_shares":13205},"source":{"system":"sec-edgar","filing":"0001437749-21-016790","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921016790/rdgdoc.xml","form_type":"4"}},{"id":2636481,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-07-12T21:57:44.000Z","date":"2021-07-11","kind":"tax_withholding","acquired":false,"shares":3215,"price":3.56,"value":11445.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":192401,"source":{"system":"sec-edgar","filing":"0001437749-21-016790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921016790/rdgdoc.xml","form_type":"4"}},{"id":2636480,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-07-12T21:57:44.000Z","date":"2021-07-11","kind":"exercise","acquired":true,"shares":13205,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":195616,"source":{"system":"sec-edgar","filing":"0001437749-21-016790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921016790/rdgdoc.xml","form_type":"4"}},{"id":2642191,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2021-07-06T11:30:25.000Z","date":"2021-07-02","kind":"exercise","acquired":false,"shares":14718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 58,869 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":717651,"derivative":{"underlying":"Common Stock","underlying_shares":14718},"source":{"system":"sec-edgar","filing":"0001437749-21-016394","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921016394/rdgdoc.xml","form_type":"4"}},{"id":2642190,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-07-06T11:30:25.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":3584,"price":3.56,"value":12759.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":182411,"source":{"system":"sec-edgar","filing":"0001437749-21-016394","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921016394/rdgdoc.xml","form_type":"4"}},{"id":2642189,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-07-06T11:30:25.000Z","date":"2021-07-02","kind":"exercise","acquired":true,"shares":14718,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":185995,"source":{"system":"sec-edgar","filing":"0001437749-21-016394","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921016394/rdgdoc.xml","form_type":"4"}},{"id":2662054,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2021-06-21T20:20:49.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":728785,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-21-015274","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921015274/rdgdoc.xml","form_type":"4"}},{"id":2662053,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2021-06-21T20:20:49.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":223635,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest in four equal annual installments, beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":628785,"derivative":{"exercise_price":3.73,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":223635},"source":{"system":"sec-edgar","filing":"0001437749-21-015274","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774921015274/rdgdoc.xml","form_type":"4"}},{"id":2747668,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-04-16T21:22:28.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":113000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The stock option was approved by the compensation committee of Soliton Inc.'s board of directors on January 21, 2021, subject to shareholder approval of the 2018 Stock Plan under which the option was granted. The shareholders of Soliton, Inc. approved the plan at the company's annual meeting on April 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The options were issued in connection with the reporting person's Board of Director service to the Company"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options set forth in this table vest in four equal annual installments and are subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1074867,"derivative":{"exercise_price":9.74,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":113000},"source":{"system":"sec-edgar","filing":"0001548187-21-000027","document":"wf-form4_161860813440856.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000154818721000027/wf-form4_161860813440856.xml","form_type":"4"}},{"id":3083868,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2020-07-14T22:03:53.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":79227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 316,907 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 11, 2019, the reporting person was granted 316,907 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2430891,"derivative":{"underlying":"Common Stock","underlying_shares":79227},"source":{"system":"sec-edgar","filing":"0001659617-20-000178","document":"wf-form4_159476421761509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000165961720000178/wf-form4_159476421761509.xml","form_type":"4"}},{"id":3083867,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-07-14T22:03:53.000Z","date":"2020-07-13","kind":"tax_withholding","acquired":false,"shares":19292,"price":0.856,"value":16513.952,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":1027659,"source":{"system":"sec-edgar","filing":"0001659617-20-000178","document":"wf-form4_159476421761509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000165961720000178/wf-form4_159476421761509.xml","form_type":"4"}}],"next_cursor":"2020-07-14T22:03:53.000000Z,3083867"}